Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas

Table 3 Analysis of biochemical results for two groups of patients

	Qinghai NAFLD group (n = 585)	Tianjin NAFLD group (n = 91)	P value
ALT	27 (19, 41)	30.9 (16.9, 59.4)	0.462
AST	23 (19, 29)	26.4 (19.4, 43.1)	0.022
GGT	30 (21, 44)	46.6 (25.2, 83)	< 0.001
ALP	81 (70, 96.25)	72.7 (60.3, 92.3)	0.098
ALB	44 (40.075, 46.5)	44.6 (42.8, 46.8)	0.348
TBIL	17.55 (13.575, 25)	16.2 (13, 19.9)	< 0.002
DBIL	6 (4.4, 8)	2.2 (1.6, 2.7)	< 0.001
IBIL	11.6 (8.975, 16.8)	14 (10.4, 17.1)	0.061
Glu	5.31 (4.71, 6.25)	5.92 (5.42, 6.58)	< 0.001
TG	1.95 (1.39, 2.79)	1.61 (1.23, 2.38)	< 0.001
TC	4.725 (4.04, 5.27)	5.69 (5.05, 6.24)	< 0.001
TBA	3.245 (1.975, 5.513)	2.3 (1.4, 5.3)	0.044
BUN	5.275 (4.34, 6.27)	5 (3.8, 6)	0.006
CRE	67.25 (57.4, 76.8)	63.4 (56.8, 71)	0.459
UA	362 (305, 427.25)	354.1 (308.6, 457.7)	0.503
HDL	1.01 (0.85, 1.18)	1.31 (1.2, 1.55)	< 0.001
LDL	2.86 (2.42, 3.29)	3.24 (2.88, 3.84)	< 0.001
WBC	6.3 (5.4, 7.4)	6.34 (4.83, 7.23)	0.835
RBC	5.3 (4.9, 5.7)	4.72 (4.42, 5.08)	< 0.001
HGB	163 (151, 176)	146 (132, 154)	< 0.001
PLT	193 (150, 226)	244 (203, 274)	< 0.001

NAFLD: Non-alcoholic fatty liver disease; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Γ-glutamyl transpeptidase; ALP: Alkaline phosphatase; ALB: Albumin; TBIL: Total bilirubin; DBIL: Direct bilirubin; IBIL: Indirect bilirubin; GLU: Glucose; TG: Triglycerides; TC: Total cholesterol; TBA: Total bile acids; BUN: Blood urea nitrogen; CRE: Creatinine; UA: Uric acid; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; WBC: White blood cell count; RBC: Red blood cell count; HGB: Hemoglobin; PLT: Platelet count.